Ceva Animal Health has appointed Sébastien Huron as Deputy Chief Executive Officer with immediate effect.

The move forms part of a broader governance evolution, following Marc Prikazsky's decision to appoint a Deputy CEO and move to a dual leadership structure in which he becomes Executive Chairman, overseeing long term strategic priorities, while Sébastien Huron steers the Group's operational management and chairs the Executive Committee.

As Executive Chairman, Marc Prikazsky will concentrate on Ceva's long-term agenda, including strengthening the trusted and longstanding relationships the company maintains with its investors, leading customer focused innovation, developing future leaders, and reinforcing Ceva's role in addressing major global challenges.

Marc Prikazsky commented: "This governance evolution reflects the scale Ceva has reached and our ambition to reinforce both strategic focus and operational excellence. I am delighted to welcome Sébastien, whose experience, global outlook and deeply human leadership will be key assets. I have full confidence in his ability to lead our teams with ambition, courage and pragmatism. Sébastien and I will work closely to ensure continuity while accelerating Ceva's next phase of development."

A veterinarian trained at the National Veterinary School of Toulouse, Sébastien Huron began his career in 1994 at Mars Inc. in France, working in marketing for the pet food division. Later that year, he moved to Brazil to join Roussel-Uclaf / Hoechst Roussel Vet, where he spent six years in various leadership roles across marketing, R&D and business development for Latin America and Brazil.

In 2000, he relocated to the United States to join Intervet, first as Director of the Market Development Group for North America, then as Director of the Companion Animals Business Team.

He returned to Europe in 2006, taking responsibility for Southern Europe at Virbac before being appointed Area Director for Europe in 2008. He later joined the Group's Executive Board and became Head of Global Business Operations. From 2017 to 2024, he served as CEO of Virbac, leading the company through a period of record organic growth.